Log in

OXB Oxford BioMedica plc LSE · United Kingdom

Oxford BioMedica (OXB) news

Oxford BioMedica plc is a public biotech or pharmaceutical company listed on LSE under the ticker OXB, recorded under United Kingdom. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Oxford BioMedica news

We have not published a story on Oxford BioMedica yet. When there is news, it will appear here.

Questions about Oxford BioMedica

What is the ticker symbol of Oxford BioMedica?

Oxford BioMedica plc trades under the ticker OXB on LSE.

Where is Oxford BioMedica listed?

Oxford BioMedica plc is listed on LSE. Our directory also records these other listings: GETTEX:OXOA; LSX:A2JLRX; OTC:OXBDF.

Which country or territory is Oxford BioMedica listed under?

Our directory records Oxford BioMedica plc under United Kingdom.

What does Oxford BioMedica do?

Our directory classifies Oxford BioMedica plc as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Oxford BioMedica?

The ISIN recorded for Oxford BioMedica plc is GB00BDFBVT43.

Does aibio.space cover Oxford BioMedica?

aibio.space lists Oxford BioMedica plc among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Oxford BioMedica?

Companies in our directory listed in the same country and business area as Oxford BioMedica: NuCana, HemoGenyx Pharmaceuticals Plc, OptiBiotix Health, Scancell Holdings Plc, OKYO Pharma, Genflow Biosciences Plc.

Investor discussion: Oxford BioMedica

Members talk about Oxford BioMedica (OXB). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open LSE:OXB on TradingView.

Listing details

Oxford BioMedica plc is a public biotech or pharmaceutical company listed on LSE under the ticker OXB, recorded under United Kingdom. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Oxford BioMedica plc
Ticker
OXB
Listing
LSE
Country or territory
United Kingdom
Business scope
Biotechnology
ISIN
GB00BDFBVT43
Other listed symbols
GETTEX:OXOA; LSX:A2JLRX; OTC:OXBDF
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.